These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2851053)

  • 1. Why do some drugs preferentially block open sodium channels?
    Courtney KR
    J Mol Cell Cardiol; 1988 Jun; 20(6):461-4. PubMed ID: 2851053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State-dependent trapping of flecainide in the cardiac sodium channel.
    Ramos E; O'leary ME
    J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
    Ragsdale DS; Scheuer T; Catterall WA
    Mol Pharmacol; 1991 Nov; 40(5):756-65. PubMed ID: 1658608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcainide causes two modes of open-channel block with different voltage sensitivities in batrachotoxin-activated sodium channels.
    Zamponi GW; French RJ
    Biophys J; 1994 Sep; 67(3):1028-39. PubMed ID: 7811913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
    Aoike F; Takahashi MP; Sakoda S
    Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion of "Why do some drugs preferentially block open sodium channels?": consideration of other significant factors in the binding process.
    Rhodes DG; Herbette LG
    J Mol Cell Cardiol; 1988 Jun; 20(6):571-2. PubMed ID: 2851056
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic drugs and the cardiac sodium channel: current models.
    Sheldon RS; Hill RJ; Duff HJ
    Clin Chem; 1989 May; 35(5):748-54. PubMed ID: 2541948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells.
    Grant AO; Chandra R; Keller C; Carboni M; Starmer CF
    Biophys J; 2000 Dec; 79(6):3019-35. PubMed ID: 11106609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of drug interaction with the sodium channel.
    Grant AO
    Clin Invest Med; 1991 Oct; 14(5):447-57. PubMed ID: 1660367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.
    Qu Y; Rogers J; Tanada T; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11839-43. PubMed ID: 8524860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AN-132 block of cardiac sodium channels: a gate-related receptor analysis.
    Wu YJ; Fang DC
    J Tongji Med Univ; 1993; 13(1):1-5. PubMed ID: 8392109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
    Valenzuela C; Snyders DJ; Bennett PB; Tamargo J; Hondeghem LM
    Circulation; 1995 Nov; 92(10):3014-24. PubMed ID: 7586272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (mu 1) channels.
    Nuss HB; Tomaselli GF; Marbán E
    J Gen Physiol; 1995 Dec; 106(6):1193-209. PubMed ID: 8786356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of inactivation-deficient Na+ channels by local anesthetics in stably transfected mammalian cells: evidence for drug binding along the activation pathway.
    Wang SY; Mitchell J; Moczydlowski E; Wang GK
    J Gen Physiol; 2004 Dec; 124(6):691-701. PubMed ID: 15545401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.
    Sheldon RS; Duff HJ; Hill RJ
    Clin Invest Med; 1991 Oct; 14(5):458-65. PubMed ID: 1660368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine alters activation gating of cardiac Na channels.
    Hanck DA; Makielski JC; Sheets MF
    Pflugers Arch; 2000 Apr; 439(6):814-21. PubMed ID: 10784357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of local anesthesia: a review.
    Butterworth JF; Strichartz GR
    Anesthesiology; 1990 Apr; 72(4):711-34. PubMed ID: 2157353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform-specific lidocaine block of sodium channels explained by differences in gating.
    Nuss HB; Kambouris NG; Marbán E; Tomaselli GF; Balser JR
    Biophys J; 2000 Jan; 78(1):200-10. PubMed ID: 10620286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Slow inactivation and blockade of sodium channels of excitable membranes by chemical compounds].
    Khodorov BI
    Patol Fiziol Eksp Ter; 1992; (4):24-30. PubMed ID: 1338921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.